{"transactions":[{"id":1044132,"issuer":{"id":9083,"kind":"organization","name":"ADAPTIN BIO, INC."},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-10T20:59:40.000Z","date":"2025-09-08","kind":"grant","planned":false,"acquired":true,"shares":192231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025."}],"balance_after":192231,"derivative":{"exercise_price":4.4,"expiration_date":"2035-09-07","underlying":"Common Stock","underlying_shares":192231},"source":{"system":"sec-edgar","filing":"0001213900-25-086582","document":"marketforms-70720.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025086582/marketforms-70720.xml","form_type":"4"}},{"id":2612850,"issuer":{"id":113753,"kind":"organization","name":"Athenex, Inc.","symbol":"ATNX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-08-05T17:07:49.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on August 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on August 3, 2022."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-049982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1300699/000120919121049982/doc4.xml","form_type":"4"}},{"id":2612849,"issuer":{"id":113753,"kind":"organization","name":"Athenex, Inc.","symbol":"ATNX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:07:49.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in four equal annual installments beginning on August 3, 2022."}],"balance_after":30000,"derivative":{"exercise_price":3.8,"expiration_date":"2031-08-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-049982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1300699/000120919121049982/doc4.xml","form_type":"4"}},{"id":3065772,"issuer":{"id":113753,"kind":"organization","name":"Athenex, Inc.","symbol":"ATNX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-06T16:45:10.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F4","text":"These options were granted contingent on receiving shareholder approval of the Amended and Restated 2017 Omnibus Incentive Plan, which approval was received on June 5, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option vests in four equal annual installments beginning on June 5, 2021."}],"balance_after":60000,"derivative":{"exercise_price":12.45,"expiration_date":"2030-06-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-045489","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1300699/000120919120045489/doc4.xml","form_type":"4"}},{"id":3177746,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman of the Bd"}}],"security":"Common Stock","published_at":"2020-04-13T18:59:38.000Z","date":"2020-04-09","kind":"tax_withholding","acquired":false,"shares":20901,"price":2.57,"value":53715.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares forfeited to the Issuer in connection with the satisfaction of tax liabilities incurred upon the vesting of restricted stock granted May 24, 2019."}],"balance_after":241833,"source":{"system":"sec-edgar","filing":"0001578563-20-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1316736/000157856320000016/primary_doc.xml","form_type":"4"}},{"id":3426571,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman of the Bd"}}],"security":"Common Stock","published_at":"2019-08-29T17:03:53.000Z","date":"2019-08-27","kind":"purchase","acquired":true,"shares":6734,"price":2.9849,"value":20100.3166,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades ranging from $2.97 to $2.9941. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":262734,"source":{"system":"sec-edgar","filing":"0001578563-19-000025","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1316736/000157856319000025/primary_doc.xml","form_type":"4"}},{"id":3470611,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman of the Bd"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-02T16:10:02.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Granted for service on the Board of Directors as a non-employee Board member prior to appointment to Executive Chairman of the Board."}],"balance_after":117,"derivative":{"exercise_price":5.44,"exercise_date":"2019-06-28","expiration_date":"2029-06-28","underlying":"Common Stock","underlying_shares":117},"source":{"system":"sec-edgar","filing":"0001104659-19-039028","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1316736/000110465919039028/a4.xml","form_type":"4"}},{"id":3508530,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman of the Bd"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-29T17:31:20.000Z","date":"2019-05-24","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option was granted on May 24, 2019.  One-third of the shares subject to the option will vest upon the Issuer's common stock closing at or above $8.00 per share for three consecutive trading days.  The next one-third of the shares subject to the option will vest upon the Issuer's common stock closing at or above $10.50 per share for three consecutive trading days.  The final one-third of the shares subject to the option will vest upon the Issuer's common stock closing at or above $13.00 per share for three consecutive trading days."}],"balance_after":300000,"derivative":{"exercise_price":4.98,"expiration_date":"2029-05-24","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001578563-19-000019","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1316736/000157856319000019/primary_doc.xml","form_type":"4"}},{"id":3508529,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman of the Bd"}}],"security":"Common Stock","published_at":"2019-05-29T17:31:20.000Z","date":"2019-05-24","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest 50,000 shares immediately and the tax burden of this vest is to be covered by the Issuer and the remaining shares will vest in three substantially equal installments on April 10, 2020, 2021 and 2022, provided the Reporting Person is then still providing continuous service as an employee, director or consultant."}],"balance_after":256000,"source":{"system":"sec-edgar","filing":"0001578563-19-000019","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1316736/000157856319000019/primary_doc.xml","form_type":"4"}},{"id":3523303,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman of the Bd"}}],"security":"Common Stock","published_at":"2019-05-16T16:19:13.000Z","date":"2019-05-14","kind":"purchase","acquired":true,"shares":6000,"price":5.056,"value":30336.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001578563-19-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1316736/000157856319000016/primary_doc.xml","form_type":"4"}},{"id":3553442,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman of Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-17T16:44:40.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the stock option will vest on the first anniversary of the date of grant, and the remaining two-thirds of the shares subject to the stock option will vest in equal monthly installments over the following 24 months."}],"balance_after":300000,"derivative":{"exercise_price":5.17,"expiration_date":"2029-04-15","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001578563-19-000015","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1316736/000157856319000015/primary_doc.xml","form_type":"4"}},{"id":3553553,"issuer":{"id":113753,"kind":"organization","name":"Athenex, Inc.","symbol":"ATNX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-04-17T16:19:20.000Z","date":"2019-04-16","kind":"grant","acquired":true,"shares":1402,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5310,"source":{"system":"sec-edgar","filing":"0001209191-19-024973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300699/000120919119024973/doc4.xml","form_type":"4"}},{"id":3571704,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-01T15:34:44.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":882,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":882,"derivative":{"exercise_price":5.84,"exercise_date":"2019-03-29","expiration_date":"2029-03-29","underlying":"Common Stock","underlying_shares":882},"source":{"system":"sec-edgar","filing":"0001562180-19-002070","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1316736/000156218019002070/primarydocument.xml","form_type":"4"}},{"id":3611649,"issuer":{"id":113753,"kind":"organization","name":"Athenex, Inc.","symbol":"ATNX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-05T16:27:40.000Z","date":"2018-03-27","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in four equal annual installments beginning on March 27, 2019."}],"balance_after":60000,"derivative":{"exercise_price":17.3,"expiration_date":"2028-03-27","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-19-016497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1300699/000120919119016497/doc4.xml","form_type":"4"}},{"id":3618598,"issuer":{"id":113753,"kind":"organization","name":"Athenex, Inc.","symbol":"ATNX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-04T17:47:02.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in four equal annual installments beginning on February 28, 2020."}],"balance_after":60000,"derivative":{"exercise_price":13.17,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-19-015834","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1300699/000120919119015834/doc4.xml","form_type":"4"}},{"id":3675713,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-02-06T02:48:06.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in equal amounts of 8,333 options for 11 consecutive months commencing on the one month anniversary of the grant date, and the balance of the options (8,337) vesting on the 12 month anniversary of the grant date.  Options are immediately exercisable upon vesting."}],"balance_after":100000,"derivative":{"exercise_price":0.281,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-19-002741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000089924319002741/doc4.xml","form_type":"4"}},{"id":3712720,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-02T16:49:48.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":1504,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1504,"derivative":{"exercise_price":3.23,"exercise_date":"2018-12-31","expiration_date":"2028-12-30","underlying":"Common Stock","underlying_shares":1504},"source":{"system":"sec-edgar","filing":"0001578563-19-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1316736/000157856319000004/primary_doc.xml","form_type":"4"}},{"id":3764435,"issuer":{"id":113753,"kind":"organization","name":"Athenex, Inc.","symbol":"ATNX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-11-14T18:10:54.000Z","date":"2018-11-14","kind":"purchase","acquired":true,"shares":2908,"price":10.258,"value":29830.264,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades ranging from $10.250 to $10.259. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":3908,"source":{"system":"sec-edgar","filing":"0001209191-18-058608","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300699/000120919118058608/doc4.xml","form_type":"4"}},{"id":3804056,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-01T14:14:32.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":990,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":990,"derivative":{"exercise_price":4.67,"exercise_date":"2018-09-28","expiration_date":"2028-09-28","underlying":"Common Stock","underlying_shares":990},"source":{"system":"sec-edgar","filing":"0001562180-18-004060","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1316736/000156218018004060/primarydocument.xml","form_type":"4"}},{"id":3837130,"issuer":{"id":113753,"kind":"organization","name":"Athenex, Inc.","symbol":"ATNX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-21T17:45:43.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was previously reported by Dr. Pedder. This amendment is being filed to correct the transaction date, exercise date, and expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was previously reported by Dr. Pedder. This amendment is being filed to correct the transaction date, exercise date, and expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in four equal annual installments beginning on June 13, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This option was previously reported by Dr. Pedder. This amendment is being filed to correct the transaction date, exercise date, and expiration date."}],"balance_after":130000,"derivative":{"exercise_price":11,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001209191-18-047801","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300699/000120919118047801/doc4a.xml","form_type":"4/A","original_submission_date":"2017-06-21"}},{"id":3874298,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-07-03T08:28:39.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":1012,"price":4.34,"value":4392.08,"ownership":{"direct":true},"balance_after":1012,"derivative":{"exercise_price":4.34,"exercise_date":"2018-06-29","expiration_date":"2028-06-29","underlying":"Common Stock","underlying_shares":1012},"source":{"system":"sec-edgar","filing":"0001562180-18-003182","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1316736/000156218018003182/primarydocument.xml","form_type":"4"}},{"id":3885572,"issuer":{"id":7822,"kind":"organization","name":"Oncotelic Therapeutics, Inc."},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T20:13:33.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":258171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Pedder was awarded options to purchase shares of Mateon Therapeutics, Inc. common stock, $0.01 par value per shares (the \"Stock Options\"), in connection with his service as a member of the Board of Directors pursuant to the Amended and Restated Mateon Therapeutics, Inc. 2015 Equity Incentive Plan and the Amended and Restated Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Options will vest in full on June 20, 2019, subject to Dr. Pedder's continued service on the Board of Directors as of such date."}],"balance_after":258171,"derivative":{"exercise_price":0.22,"expiration_date":"2024-06-20","underlying":"Common Stock","underlying_shares":258171},"source":{"system":"sec-edgar","filing":"0001209191-18-039172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/908259/000120919118039172/doc4.xml","form_type":"4"}},{"id":3927587,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-17T19:58:43.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":8357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in full on May 15, 2019, subject to the grantee's continued service on such vesting date."}],"balance_after":8357,"derivative":{"exercise_price":3.71,"exercise_date":"2019-05-15","expiration_date":"2028-05-14","underlying":"Common Stock","underlying_shares":8357},"source":{"system":"sec-edgar","filing":"0001578563-18-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1316736/000157856318000010/primary_doc.xml","form_type":"4"}},{"id":3966014,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-04-10T16:29:36.000Z","date":"2018-04-06","kind":"grant","acquired":true,"shares":16714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant shall vest one-third on each of the first, second and third anniversaries of the date of grant, provided Dr. Pedder is then a director of the Company."}],"balance_after":16714,"derivative":{"exercise_price":4.14,"expiration_date":"2028-04-06","underlying":"Common Stock","underlying_shares":16714},"source":{"system":"sec-edgar","filing":"0001578563-18-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1316736/000157856318000005/primary_doc.xml","form_type":"4"}},{"id":4249312,"issuer":{"id":113753,"kind":"organization","name":"Athenex, Inc.","symbol":"ATNX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"officer":true,"officer_title":"See Remarks."}}],"security":"Common Stock","published_at":"2017-07-28T16:30:33.000Z","date":"2017-06-19","kind":"purchase","acquired":true,"shares":1000,"price":11,"value":11000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of Common Stock (\"Shares\") were inadvertently omitted from the Reporting Person's Form 4 filed June 21, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These Shares were purchased in the Issuer's initial public offering, which closed on June 19, 2017."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000905148-17-000703","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300699/000090514817000703/form4.xml","form_type":"4/A","original_submission_date":"2017-06-21"}},{"id":4275207,"issuer":{"id":113753,"kind":"organization","name":"Athenex, Inc.","symbol":"ATNX"},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"officer":true,"officer_title":"See Remarks."}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-21T15:14:43.000Z","date":"2017-06-19","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on June 19, 2018."}],"balance_after":130000,"derivative":{"exercise_price":11,"expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000905148-17-000612","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1300699/000090514817000612/form4.xml","form_type":"4"}},{"id":4286214,"issuer":{"id":7822,"kind":"organization","name":"Oncotelic Therapeutics, Inc."},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-13T00:31:50.000Z","date":"2017-06-09","kind":"grant","acquired":true,"shares":121483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Pedder was awarded options to purchase shares of Mateon Therapeutics, Inc. common stock, $0.01 par value per share (the \"Stock Options\"), in connection with his service as a member of the Board of Directors pursuant to the Mateon Therapeutics, Inc. 2015 Equity Incentive Plan and the Amended and Restated Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Options will vest in full on June 9, 2018, subject to Dr. Pedder's continued service on the Board of Directors as of such date."}],"balance_after":121483,"derivative":{"exercise_price":0.51,"expiration_date":"2023-06-09","underlying":"Common Stock","underlying_shares":121483},"source":{"system":"sec-edgar","filing":"0001209191-17-039320","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/908259/000120919117039320/doc4.xml","form_type":"4"}}]}